20 Trailblazers Setting The Standard In ADHD Medication Pregnancy > 자유게시판

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from adhd focus medication have to make a difficult choice regarding whether or not to stop taking strongest adhd medication for adults medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these medications may affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological disorders like hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are required.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should weigh the benefits of taking it against the potential risks to the foetus. The doctors don't have the information to provide clear recommendations, but can provide information about risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not have an higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a large sample-based case control study to assess the frequency of structural defects that were major in infants who were born to mothers who were taking stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to ensure that the classification was accurate and to reduce any bias.

The research conducted by the researchers had some limitations. Researchers were unable in the beginning, to separate the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to determine if the small differences observed between the groups exposed were due to the use of medication or affected by the presence of comorbidities. The researchers did not examine the long-term effects for the offspring.

The study showed that infants whose mothers had taken ADHD medication during pregnancy were at a slightly higher chance of being admitted to the neonatal care unit (NICU) as compared to mothers who didn't take any medication during pregnancy or quit taking the medication prior to or during pregnancy. The reason for this was central nervous system disorders, and the increased risk of admission did not appear to be influenced by the stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medication during pregnancies in the early stages may be offset by the greater benefits for baby and mother of continued treatment for the woman’s disorder. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies to improve their coping abilities which can reduce the negative impact of her condition on her daily life and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to keep treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are frequently taken without clear and authoritative evidence. Instead, physicians must take into account their own experience in conjunction with the experiences of other doctors, and the research on the subject.

In particular, the issue of potential risks to the baby can be tricky. Many studies on this issue are based on observational data rather than controlled research, and their findings are often contradictory. The majority of studies restrict their analysis to live-births, which could underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study discussed in the journal club addresses these limitations by analyzing the data from deceased and live births.

The conclusion is that while some studies have found a positive association between common adhd medications; additional resources, medications and the risk of certain birth defects, other studies have not found any evidence of a link and the majority of studies demonstrate a neutral or slight negative effect. In every case, a careful analysis of the potential risks and benefits must be performed.

For many women with ADHD, the decision to discontinue medication is difficult, if not impossible. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. A loss of medication may also affect the ability to safely drive and complete work-related tasks, which are essential aspects of daily life for those with ADHD.

She suggests that women who are unsure whether to continue taking medication or stop due to pregnancy, educate their family members, coworkers, and their friends about the condition, the effects on daily functioning, and the benefits of keeping the current treatment regimen. Educating them can also help the woman feel supported as she struggles with her decision. Certain medications can be passed through the placenta. If a woman decides to stop taking her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the baby.

Birth Defects Risk

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns over the impact that these drugs might have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this issue. With two massive data sets researchers were able to analyze more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the researchers did find that first-trimester exposure to ADHD medications was linked to an increased risk of certain heart defects like ventriculo-septal defects (VSD).

The authors of the study could not find any association between early medication usage and other congenital anomalies, such as facial deformities or club feet. The findings are in line with previous studies revealing the presence of a small, but significant increase in the risk of heart malformations among women who started taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter stages of pregnancy when many women stopped taking their medication.

Women who took ADHD medications in the first trimester of pregnancy were also more likely to have caesarean sections, a low Apgar score following delivery, and a baby that required breathing assistance at birth. However the researchers of the study were not able to eliminate selection bias by limiting the study to women who didn't have other medical issues that could have contributed to these findings.

The researchers hope their research will aid in the clinical decisions of doctors who encounter pregnant women. They suggest that although the discussion of the benefits and risks is important, the decision to stop or continue treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an alternative, it is not an option that is recommended due to the high prevalence of depression and other mental health issues in women who are pregnant or who are recently postpartum. Research has also shown that women who stop taking their medication will have a tough transitioning to life without them after the baby is born.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments and preparing for the arrival of a baby and adjusting to new household routines are often faced with a number of difficulties. Therefore, many women elect to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant drugs are absorbed by breast milk in low amounts, so the risk to breastfeeding infant is minimal. However, the rate of medication exposure to the infant can differ based on the dosage, frequency it is administered and at what time it is administered. In addition, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn isn't yet fully understood.

Some physicians may discontinue stimulant medications during a woman's pregnancy due to the absence of research. It is a difficult decision for the woman, who must weigh the benefits of her medication against the risk to the foetus. Until more information becomes available, GPs may inquire about pregnant patients if they have a history of ADHD or if they intend to take medication during the perinatal period.

Numerous studies have proven that women can continue to take their ADHD medication in a safe manner during pregnancy and breast-feeding. In response, a growing number of patients are opting to continue their medication. They have found after consulting with their doctor, that the benefits of keeping their current medication far outweigh any possible risks.

Women with ADHD who are planning to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD recognize their symptoms and the root cause and learn about treatment options and strengthen existing coping strategies. This should involve a multidisciplinary approach, which includes the GP doctors, obstetricians and psychiatrists. Counselling for pregnancy should include the discussion of a treatment plan for both mother and child, and monitoring for signs of deterioration and the need for adjustments to the medication regimen.